How BC Unify works: A conversation on the AI-native platform behind our solutions
Inside BC Unify: how our AI-native platform turns fragmented real-world data into high-quality, research-ready datasets at scale.
The world of research is at an inflection point. On one hand, data-driven insights can transform patient care, accelerate drug discovery, and improve public health. On the other, privacy concerns, regulatory constraints, and fragmented data sources continue to slow progress. How can organizations strike the right balance between innovation and security?
The answer lies in TREs โ also known as Secure Data Environments (SDEs) or Data Safe Havens โ which provide a secure space for researchers to access and analyse health data without compromising privacy or compliance.
A Trusted Research Environment provides a secure space where Real-World Data can be accessed and analysed without compromising privacy. In pharmaceutical and life sciences research, it enables advanced analytics on large datasets, supporting drug development, safety monitoring, and evidence-based decision-makingโall while ensuring data security and regulatory compliance. Turning data into knowledge, safely and responsibly!
ร sa Carlsheimer, Data Science and Analytics, BC Platforms
The โtrustโ in Trusted Research Environments must be earned through rigorous safeguards and accountability. As a BMJ analysis notes, โTrust should be built on transparency, governance, and accountability โ not assumed as a given.โ [1]
TREs allow approved researchers to work with sensitive, pseudonymised datasets in a fully governed setting. Unlike traditional data-sharing models that require duplication or extraction, TREs keep data centralized, reducing the risk of breaches while maintaining access to analytical tools and diverse datasets.
Data custodians such as hospitals, biobanks, and research institutions ensure datasets remain secure and governed, accessible only to authorized users [2]. In a 2018 study, data sensitivity was cited as the top concern for 66 % of medical researchers โ reinforcing the need for privacy-first solutions.
Lack of standardization also poses challenges. As reported in the International Journal of Population Data Science, โInteroperability remains a major barrier to seamless health-data sharing. Without standardized frameworks, researchers struggle to collaborate across TREs.โ [3]
By enabling secure collaboration and reducing inefficiencies, TREs empower researchers to extract insights faster and drive scientific breakthroughs โ while maintaining alignment with GDPR, HIPAA, and other data-protection frameworks.
TREs are essential for unlocking the full potential of Real-World Data, enabling researchers to collaborate across institutions while ensuring privacy-first, federated access.
Lifebit, The Complete Guide to Trusted Research Environments [4]
While TREs enhance data security, interoperability between systems often remains a challenge. A PHG Foundation report notes that โResearchers accessing multiple TREs must navigate complex governance structures and data-use agreements, causing delays in research.โ [5]
BC Platformsโ TRE solution eliminates these barriers. Built on a cloud-agnostic, federated architecture, it offers seamless, privacy-preserving access to global, research-ready, regulatory-grade patient data โ compliant with GDPR, HIPAA, and ISO 27001.
By integrating federated data discovery, advanced data management, and secure researcher workspaces, BC Platforms enables:
This approach helps hospitals, research institutions, and pharma organizations collaborate securely while maintaining governance, compliance, and performance.
Europe is leading the way with the European Health Data Space (EHDS), a transformative initiative creating a unified, interoperable framework for secure, cross-border data sharing.
As regulations like GDPR and EHDS evolve, TREs will become the standard for ethical, secure, and scalable health-data research across borders.
Lifebit, The Complete Guide to Trusted Research Environments [4]
BC Platformsโ EHDS-ready TRE supports this vision, empowering healthcare institutions to collaborate on large-scale studies, helping pharmaceutical companies conduct regulatory-grade research, and enabling public-health agencies to monitor disease trends and policy outcomes. This new era of health-data collaboration will accelerate scientific discoveries, improve patient outcomes, and position Europe as a global leader in ethical, secure health-data research.
Explore how our Trusted Research Environment powers the next generation of Real-World Data collaboration โ or reach ou to discuss your specific needs.